vs
STANDARD BIOTOOLS INC.（LAB）与Ready Capital Corp（RC）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是Ready Capital Corp的1.5倍（$19.6M vs $13.1M），STANDARD BIOTOOLS INC.净利率更高（-177.4% vs -1772.7%，领先1595.3%），STANDARD BIOTOOLS INC.同比增速更快（-11.5% vs -73.8%），过去两年STANDARD BIOTOOLS INC.的营收复合增速更高（-12.2% vs -48.0%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
Ready Capital Corp是一家总部位于美国的商业地产金融企业，提供多户住宅贷款、小型商业地产抵押贷款、建筑融资及抵押贷款服务等定制化解决方案，核心客户覆盖美国各地的房地产投资者、小型企业运营者及地产开发商。
LAB vs RC — 直观对比
营收规模更大
LAB
是对方的1.5倍
$13.1M
营收增速更快
LAB
高出62.3%
-73.8%
净利率更高
LAB
高出1595.3%
-1772.7%
两年增速更快
LAB
近两年复合增速
-48.0%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $13.1M |
| 净利润 | $-34.7M | $-232.6M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | -2013.3% |
| 净利率 | -177.4% | -1772.7% |
| 营收同比 | -11.5% | -73.8% |
| 净利润同比 | -28.8% | 26.1% |
| 每股收益（稀释后） | $-0.09 | $-1.43 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABRC
| Q4 25 | — | $13.1M | ||
| Q3 25 | $19.6M | $85.4M | ||
| Q2 25 | $21.8M | $16.9M | ||
| Q1 25 | $40.8M | $40.2M | ||
| Q4 24 | — | $50.1M | ||
| Q3 24 | $22.1M | $107.2M | ||
| Q2 24 | $22.5M | $51.0M | ||
| Q1 24 | $45.5M | $48.5M |
净利润LABRC
| Q4 25 | — | $-232.6M | ||
| Q3 25 | $-34.7M | $-16.7M | ||
| Q2 25 | $-33.5M | $-53.7M | ||
| Q1 25 | $-26.0M | $82.0M | ||
| Q4 24 | — | $-314.8M | ||
| Q3 24 | $-26.9M | $-7.3M | ||
| Q2 24 | $-45.7M | $-34.2M | ||
| Q1 24 | $-32.2M | $-74.2M |
毛利率LABRC
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
营业利润率LABRC
| Q4 25 | — | -2013.3% | ||
| Q3 25 | -168.5% | -31.5% | ||
| Q2 25 | -118.1% | -524.9% | ||
| Q1 25 | -80.8% | — | ||
| Q4 24 | — | -629.0% | ||
| Q3 24 | -120.9% | -14.8% | ||
| Q2 24 | -134.5% | -157.0% | ||
| Q1 24 | -132.2% | -217.9% |
净利率LABRC
| Q4 25 | — | -1772.7% | ||
| Q3 25 | -177.4% | -19.6% | ||
| Q2 25 | -153.7% | -317.7% | ||
| Q1 25 | -63.8% | 203.7% | ||
| Q4 24 | — | -628.8% | ||
| Q3 24 | -122.0% | -6.8% | ||
| Q2 24 | -203.3% | -67.1% | ||
| Q1 24 | -70.6% | -152.8% |
每股收益（稀释后）LABRC
| Q4 25 | — | $-1.43 | ||
| Q3 25 | $-0.09 | $-0.13 | ||
| Q2 25 | $-0.09 | $-0.34 | ||
| Q1 25 | $-0.07 | $0.46 | ||
| Q4 24 | — | $-1.89 | ||
| Q3 24 | $-0.07 | $-0.07 | ||
| Q2 24 | $-0.12 | $-0.23 | ||
| Q1 24 | $-0.27 | $-0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $207.8M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $399.7M | $1.5B |
| 总资产 | $539.6M | $7.8B |
| 负债/权益比越低杠杆越低 | — | 0.89× |
8季度趋势，按日历期对齐
现金及短期投资LABRC
| Q4 25 | — | $207.8M | ||
| Q3 25 | $129.4M | $147.5M | ||
| Q2 25 | $158.6M | $162.9M | ||
| Q1 25 | $150.9M | $205.9M | ||
| Q4 24 | — | $143.8M | ||
| Q3 24 | $210.6M | $181.3M | ||
| Q2 24 | $269.8M | $226.3M | ||
| Q1 24 | $287.1M | $166.0M |
总债务LABRC
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | $55.2M | $1.2B | ||
| Q2 24 | $55.1M | $1.2B | ||
| Q1 24 | $55.0M | $1.1B |
股东权益LABRC
| Q4 25 | — | $1.5B | ||
| Q3 25 | $399.7M | $1.8B | ||
| Q2 25 | $424.5M | $1.8B | ||
| Q1 25 | $454.6M | $1.9B | ||
| Q4 24 | — | $1.8B | ||
| Q3 24 | $489.3M | $2.2B | ||
| Q2 24 | $510.3M | $2.3B | ||
| Q1 24 | $577.3M | $2.4B |
总资产LABRC
| Q4 25 | — | $7.8B | ||
| Q3 25 | $539.6M | $8.3B | ||
| Q2 25 | $557.0M | $9.3B | ||
| Q1 25 | $579.6M | $10.0B | ||
| Q4 24 | — | $10.1B | ||
| Q3 24 | $681.5M | $11.3B | ||
| Q2 24 | $708.7M | $11.8B | ||
| Q1 24 | $777.7M | $12.0B |
负债/权益比LABRC
| Q4 25 | — | 0.89× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 0.76× | ||
| Q1 25 | — | 0.77× | ||
| Q4 24 | — | 0.73× | ||
| Q3 24 | 0.11× | 0.54× | ||
| Q2 24 | 0.11× | 0.52× | ||
| Q1 24 | 0.10× | 0.46× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $432.1M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | — |
| 自由现金流率自由现金流/营收 | -118.1% | — |
| 资本支出强度资本支出/营收 | 4.5% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | — |
8季度趋势，按日历期对齐
经营现金流LABRC
| Q4 25 | — | $432.1M | ||
| Q3 25 | $-22.2M | $434.7M | ||
| Q2 25 | $-20.7M | $-100.3M | ||
| Q1 25 | $-30.3M | $108.5M | ||
| Q4 24 | — | $274.8M | ||
| Q3 24 | $-27.9M | $221.1M | ||
| Q2 24 | $-39.0M | $1.1M | ||
| Q1 24 | $-62.5M | $23.4M |
自由现金流LABRC
| Q4 25 | — | — | ||
| Q3 25 | $-23.1M | — | ||
| Q2 25 | $-22.6M | — | ||
| Q1 25 | $-35.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-30.1M | — | ||
| Q2 24 | $-41.0M | — | ||
| Q1 24 | $-63.3M | — |
自由现金流率LABRC
| Q4 25 | — | — | ||
| Q3 25 | -118.1% | — | ||
| Q2 25 | -103.6% | — | ||
| Q1 25 | -86.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -136.4% | — | ||
| Q2 24 | -182.2% | — | ||
| Q1 24 | -138.9% | — |
资本支出强度LABRC
| Q4 25 | — | — | ||
| Q3 25 | 4.5% | — | ||
| Q2 25 | 8.7% | — | ||
| Q1 25 | 12.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.2% | — | ||
| Q2 24 | 8.6% | — | ||
| Q1 24 | 1.7% | — |
现金转化率LABRC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.32× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
RC
暂无分部数据
